Elsamitrucin (SPP-28090)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elsamitrucin (SPP-28090), covering 2014-05-21 to 2014-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]